Acting Attorney General Todd Blanche signed an order moving two categories of marijuana into Schedule III of the Controlled Substances Act: FDA-approved drug products containing marijuana, and marijuana products regulated under a qualifying state medical marijuana license. The action was announced by the Department of Justice on April 23 and follows a December 18, 2025 executive order in which President Trump directed the DOJ to complete the reclassification “in the most expeditious manner possible.”
